Location: Home
  • search
  • go
  • Relate News
  • 10/29/20133SBio Acquires Patents of New Renal Drug from SIMM
  • 10/28/2013Most Listed Chinese Pharma Companies Saw Improving Performance in 3Qs/...
  • 10/28/2013Jiaying Pharma Completes Acquisition of Jinsha Pharma as Hansen Plans ...
  • 10/25/2013Cholesterol-Reduction Drug Consumption in Shanghai Hospitals 2010-2012...
  • 10/25/2013ShangPharma Appoints Biogen Idec Executive to President and CSO
  • 10/23/2013CFDA Seeks Public Comments on Draft Guidelines on Quality Equivalence ...
  • 10/23/2013CFDA Solicits Public Comments on Drug Regulatory Information Standards
  • 10/22/2013Global Pharma Outsourcing on Strong Growth Path
  • 10/22/2013McKinsey: In Search of New Growth Models for Big Pharma in China (Upda...
  • 10/21/2013Yiling Pharma and Cardiff University Collaborate on Research of Modern...
  • 10/18/2013Synthetic Biology Partnering Award Promotes Links between UK and Chin...
  • 10/18/2013Ablynx, Eddingpharm Enter Licensing Deal for Osteoporosis Drug Candida...
  • 10/18/2013Sino-French Research Institute for Immunology Established in Guangzhou
  • 10/17/2013China Allocates CNY 2.2B to Boost Healthcare Service and Related Secto...
  • 10/17/2013WuXi PharmaTech Obtains First CLIA Certification in China
  • 10/17/2013CFDA Revises Packages Inserts of Four Drug Products
  • 10/16/2013Chinese Government Allocates More Funds to Support TCM
  • 10/16/2013Sanofi Completes Poultry Vaccine Plant Expansion in Nanchang
  • 10/15/2013Simcere Pharma Appoints Former GSK China R&D Chief to CSO
  • 10/15/2013Data Snapshot: Chinese Pharma Industry Performance in H1/2013
  • 10/15/2013Eddingpharm Accused of Physician Briberies for Sales of MNC Drugs
  • 10/14/2013Updated: State Council Issues New Policy to Promote Healthcare Service...
  • 10/11/2013Chipscren, GNT to Co-develop/Co-market Cancer Drug in Taiwan
  • 10/11/2013Merck to Cut China Investment Budget?
  • 10/11/2013Listed Chinese Pharma Companies Report Upbeat Performance in First Thr...
  • 10/10/2013Immutep, Eddingpharm Ink China Licensing Agreement for IMP321
  • 10/9/2013Eli Lilly, Chi-Med Enter Licensing/Co-development Deal for Cancer Drug
  • 10/9/2013CDIBP Wins WHO Pre-qualification for JE Vaccine
  • 10/8/2013Hypertension and Dementia Prevalence on Sharp Rise among Younger Chine...
  • 10/8/2013Chinese Biopharma M&A to be Driven by Well-funded Regional Players
  • Page:266/367 Total number of articles:10993: [First][<<] [264] [265] [266] [267] [268] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group